TB-500 + BPC-157

A PharmaTech-formulated blend of the two peptides most studied together for tissue repair: TB-500, a synthetic fragment of thymosin β4, and BPC-157, a pentadecapeptide derived from a gastric protein sequence. TB-500 acts on actin regulation and cell migration; BPC-157 is described in the literature as acting on growth-factor and angiogenic pathways. The two are combined because they address repair through different mechanisms.

Soft-tissue repair, tendon and ligament recovery, and angiogenesis — largely in animal models.

Lyophilized. Reconstitute with bacteriostatic water per the general reference below.

General reconstitution & storage reference for lyophilized peptides:

1. 1Reconstitute with bacteriostatic water (0.9% benzyl alcohol) rather than plain sterile water — the preservative meaningfully extends usable shelf life.
2. 2In bacteriostatic water, refrigerate at 2–8°C, typically usable for ~28–30 days. In plain sterile water (no preservative): 7–14 days.
3. 3Lyophilized (unmixed) vials are stable at refrigerated or, for some peptides, frozen temperatures for extended periods prior to reconstitution.
4. 4Avoid repeated freeze-thaw cycles, direct light/UV exposure, and heat — these are the primary drivers of peptide degradation.
5. 5Reconstitute gently: inject the water down the inside wall of the vial and swirl — don't shake, which can denature the peptide structure.

Inherits the precautions of both components. Neither peptide is approved by any regulatory agency, and both are on WADA's prohibited list for competitive athletes.

• PubMed — BPC-157
• PubMed — TB-500 / thymosin beta-4